subject: UMLS:C4721495


subject: UNII:200AW54D93

subject_name: PEMZIVIPTADIL

object_name: pulmonary hypertension, primary, 1

tested_intervention: unsure


subject: UNII:200AW54D93

object_name: pulmonary hypertension


subject: UNII:200AW54D93

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:200AW54D93

object_name: pulmonary arterial hypertension


subject: UMLS:C5392699


subject: UMLS:C5392699


subject: UMLS:C5392699


subject: UMLS:C5392699


subject: UMLS:C2983753

object_name: Advanced Adult Hepatocellular Carcinoma

tested_intervention: yes


subject: UMLS:C0768182

subject_name: Bexxar

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C0768182

object_name: non-Hodgkin lymphoma


subject: CHEBI:9765

subject_name: Trypsin

object_name: Symptomatic irreversible pulpitis


subject: PUBCHEM.COMPOUND:74981710

subject_name: Bromelain


subject: UMLS:C0006217

subject_name: bromelains


subject: UMLS:C0293742

subject_name: stem bromelain


subject: CHEBI:28527

subject_name: Rutin


subject: CHEBI:4875

subject_name: Etanercept

object_name: pulmonary fibrosis


subject: CHEBI:4875

object_name: Pulmonary Fibrosis, CTCAE


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: CHEBI:5109

subject_name: Fluocinonide

object_name: exanthem


subject: CHEBI:5109

object_name: Eruptions


subject: CHEBI:16199

subject_name: Urea


subject: CHEBI:16199


subject: CHEBI:46858

subject_name: L-tyrosine residue

object_name: Hirsutism


subject: CHEBI:46858

object_name: Hirsutism, CTCAE


subject: CHEBI:46858

object_name: Androgen excess


subject: CHEBI:46858

object_name: Menstrual disorder


subject: CHEBI:17895

subject_name: Tyrosine


subject: CHEBI:17895


subject: CHEBI:17895


subject: CHEBI:17895


subject: CHEBI:24848

subject_name: inositol


subject: CHEBI:24848


subject: CHEBI:24848


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: proteinuria


subject: CHEBI:28939

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:28939

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:28939

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:28939

object_name: Diabetes


subject: CHEBI:28939

object_name: diabetes mellitus


subject: UNII:2SPH1IMO2V

subject_name: N-Acetyl-D-cysteine


subject: UNII:2SPH1IMO2V


subject: UNII:2SPH1IMO2V


subject: UNII:2SPH1IMO2V


subject: UNII:2SPH1IMO2V

object_name: type 2 diabetes mellitus


subject: UNII:2SPH1IMO2V


subject: UNII:2SPH1IMO2V


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Recurrent Endometrial Cancer


subject: CHEBI:63605

subject_name: Ixabepilone


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: infertility


subject: CHEMBL.COMPOUND:CHEMBL4298127

object_name: HIV infection


subject: PUBCHEM.COMPOUND:4456137

subject_name: Epothilone B

object_name: breast neoplasm


subject: CHEBI:31550

subject_name: Patupilone


subject: UMLS:C3489972

object_name: venous thromboembolism


subject: UMLS:C3489972

object_name: thrombophilia due to thrombin defect


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Inflammatory carcinoma of breast recurrent


subject: UNII:DPT0O3T46P

object_name: Inflammatory carcinoma of breast stage IV


subject: UNII:DPT0O3T46P

object_name: Peau d'orange


subject: UNII:DPT0O3T46P

object_name: Erythema


subject: UNII:DPT0O3T46P

object_name: Edema


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: CHEBI:8378

subject_name: Prednisolone


subject: UMLS:C0699320

subject_name: Endoxan


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: necrotizing fasciitis


subject: CHEBI:73604

object_name: fournier gangrene


subject: CHEBI:36791

subject_name: Escitalopram

object_name: coronary artery disorder


subject: CHEBI:36791

object_name: coronary atherosclerosis


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:9123

subject_name: Sertraline

object_name: cardiovascular disorder


subject: CHEBI:9123


subject: CHEBI:9123


subject: UNII:IY90U61Z3S

subject_name: ARGATROBAN

object_name: heparin-induced thrombocytopenia


subject: UNII:0DW7MIH1VX

subject_name: Argatroban


subject: CHEBI:48720

subject_name: argatroban


subject: CHEBI:6078

subject_name: Ivermectin

object_name: Post-kala-azar dermal leishmaniasis


subject: CHEBI:6078

object_name: leishmaniasis


subject: CHEBI:75283

subject_name: Miltefosine


subject: CHEBI:156095

subject_name: Lumefantrine

object_name: Malaria, Vivax


subject: CHEBI:17026

subject_name: Progesterone

object_name: Menstrual disorder


subject: CHEBI:48923

subject_name: erythromycin

object_name: hepatic encephalopathy


subject: CHEBI:48923

object_name: portal hypertension


subject: CHEBI:48923

object_name: liver cirrhosis


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: CHEBI:42355


subject: CHEBI:7507

subject_name: Framycetin


subject: CHEBI:7507


subject: CHEBI:7507


subject: CHEBI:6427

subject_name: Leuprolide

object_name: Embolism, Tumor


subject: CHEBI:6427

object_name: Neoplasm Metastasis


subject: CHEBI:6427

object_name: Metastatic Lesion


subject: UNII:834YJF89WO

subject_name: Belumosudil

object_name: diffuse cutaneous systemic sclerosis


subject: UNII:834YJF89WO

object_name: diffuse scleroderma


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Tobacco user


subject: UMLS:C0358855

object_name: Tobacco use history


subject: UMLS:C0358855

object_name: Encounter due to tobacco use


subject: CHEBI:74947

subject_name: Thalidomide

object_name: liver cancer


subject: CHEBI:74947

object_name: liver neoplasm


subject: CHEBI:74947

object_name: Adult Liver Carcinoma


subject: CHEBI:138560

object_name: acute bronchiolitis


subject: CHEBI:138560

object_name: respiratory syncytial virus infectious disease


subject: DRUGBANK:DB09337

subject_name: Medical air


subject: DRUGBANK:DB09337


subject: UNII:K21NZZ5Y0B

subject_name: AIR


subject: UNII:K21NZZ5Y0B


subject: PR:000022063

subject_name: aerotaxis receptor


subject: PR:000022063


subject: UMLS:C0001861

subject_name: Air (substance)


subject: UMLS:C0001861


subject: PUBCHEM.COMPOUND:123812

subject_name: heliox


subject: PUBCHEM.COMPOUND:123812


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Hodgkin Disease


subject: CHEBI:70839

object_name: non-Hodgkin lymphoma


subject: CHEBI:70839

object_name: lymphoid leukemia


subject: CHEBI:70839

object_name: Myelodysplasia


subject: CHEBI:70839

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:70839

object_name: childhood myelodysplastic syndrome


subject: CHEBI:70839

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:70839

object_name: myeloid leukemia


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UNII:S66Z65E10T

subject_name: CEMDISIRAN

object_name: paroxysmal nocturnal hemoglobinuria


subject: GTOPDB:12900

subject_name: pozelimab


subject: UNII:0JJ21K6L2I

subject_name: Pozelimab


subject: MESH:C587694

object_name: non-small cell lung carcinoma


subject: CHEBI:4445

subject_name: Desflurane

object_name: lung cancer


subject: CHEBI:4445

object_name: lung neoplasm


subject: CHEBI:4445

object_name: lung carcinoma


subject: CHEBI:134689

subject_name: Rucaparib

object_name: peritoneum cancer


subject: CHEBI:134689

object_name: malignant epithelial tumor of ovary


subject: CHEBI:134689

object_name: fallopian tube carcinoma


subject: CHEBI:134689

object_name: fallopian tube cancer


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: UNII:6GNT3Y5LMF

object_name: cancer


subject: UNII:6GNT3Y5LMF

object_name: neoplasm


subject: CHEBI:63598

subject_name: Levofloxacin

object_name: non-Hodgkin lymphoma


subject: CHEBI:63598


subject: CHEBI:63598


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: PUBCHEM.COMPOUND:2154

subject_name: Aminopterin

object_name: psoriasis


subject: UMLS:C4077912

object_name: type 1 diabetes mellitus 1


subject: UMLS:C4077912

object_name: type 1 diabetes mellitus


subject: CHEBI:64187

subject_name: Benserazide

object_name: Parkinson disease


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage II Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679

object_name: esophageal adenocarcinoma


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C0213891

object_name: end stage renal failure


subject: UMLS:C0213891

object_name: Chronic uremia


subject: DRUGBANK:DB17107

subject_name: Lifileucel

object_name: uveal melanoma


subject: DRUGBANK:DB17107

object_name: melanoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: mortality


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:TB7D2H7MZZ

object_name: atopic eczema


subject: UNII:TB7D2H7MZZ

object_name: pruritus chronic


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: complication


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C4764272


subject: UMLS:C5706486

subject_name: BNT 323

object_name: Locally advanced breast cancer


subject: UMLS:C5706486

object_name: Unresectable Breast Carcinoma


subject: UMLS:C5854501

subject_name: Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002


subject: UMLS:C5854501

object_name: Carcinoma breast stage IV


subject: UMLS:C5854501


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: brain neoplasm


subject: UNII:PVI5M0M1GW

object_name: central nervous system cancer


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: UMLS:C5828752

object_name: type 2 diabetes mellitus


subject: CHEBI:3219

subject_name: Bupropion

object_name: Neck Carcinoma


subject: CHEBI:3219

object_name: head and neck neoplasm


subject: CHEBI:3219

object_name: head and neck cancer


subject: CHEBI:3219

object_name: pancreatic neoplasm


subject: CHEBI:3219

object_name: exocrine pancreatic carcinoma


subject: CHEBI:3219

object_name: malignant pancreatic neoplasm


subject: CHEBI:3219

object_name: carcinoma of esophagus


subject: CHEBI:3219

object_name: esophageal cancer


subject: CHEBI:3219

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:3219

object_name: neoplasm of esophagus


subject: CHEBI:3219

object_name: cervical cancer


subject: CHEBI:3219

object_name: cervical carcinoma


subject: CHEBI:3219

object_name: liver cancer


subject: CHEBI:3219

object_name: liver neoplasm


subject: CHEBI:3219

object_name: Adult Liver Carcinoma


subject: CHEBI:3219

object_name: liver carcinoma


subject: CHEBI:3219

object_name: Stomach cancer


subject: CHEBI:3219

object_name: gastric cancer


subject: CHEBI:3219

object_name: bladder tumor


subject: CHEBI:3219

object_name: urinary bladder carcinoma


subject: CHEBI:3219

object_name: urinary bladder cancer


subject: CHEBI:3219

object_name: childhood bladder carcinoma


subject: CHEBI:3219

object_name: renal carcinoma


subject: CHEBI:3219

object_name: kidney neoplasm


subject: CHEBI:3219

object_name: kidney cancer


subject: CHEBI:3219

object_name: leukemia


subject: CHEBI:3219

object_name: childhood leukemia


subject: CHEBI:231614

object_name: Autoimmunity


subject: CHEBI:231614

object_name: inflammatory bowel disease 1


subject: CHEBI:231614

object_name: Crohn disease


subject: CHEBI:231614

object_name: temporal arteritis


subject: CHEBI:231614

object_name: EXCESS LMW-DNA


subject: CHEBI:231614

object_name: multiple sclerosis


subject: CHEBI:231614

object_name: polymyalgia rheumatica


subject: CHEBI:231614

object_name: ulcerative colitis


subject: CHEBI:231614

object_name: rheumatoid arthritis


subject: CHEBI:231614

object_name: psoriasis


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:118987284

subject_name: Nexium

object_name: Helicobacter pylori infectious disease


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:6413

subject_name: Letrozole

object_name: Complete miscarriage


subject: PUBCHEM.COMPOUND:91932556

subject_name: Etafilcon A

object_name: Visual Acuity


subject: CHEMBL.COMPOUND:CHEMBL2108231

subject_name: ETAFILCON A


subject: CHEBI:92511

subject_name: Ketotifen


subject: UNII:638KY4573I

object_name: hypertension


subject: UNII:638KY4573I

object_name: Hypertension, CTCAE


subject: UNII:PD5EII1F9A

subject_name: Firibastat


subject: UNII:PD5EII1F9A


subject: PUBCHEM.COMPOUND:131751561

subject_name: Cyclostenol

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:131751561

object_name: Chronic uremia


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: DRUGBANK:DB14276


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:5281767


subject: CHEBI:4672

subject_name: Docetaxel

object_name: urethra transitional cell carcinoma


subject: CHEBI:4672

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: CHEBI:4672

object_name: Bladder transitional cell carcinoma stage IV


subject: CHEBI:4672

object_name: Bladder transitional cell carcinoma stage III


subject: CHEBI:4672

object_name: Regional Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:4672

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:4672

object_name: Stage IV Urethral Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IV Urethral Cancer AJCC v7


subject: CHEBI:4672

object_name: Stage III Urethral Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage III Urethral Cancer AJCC v7


subject: CHEBI:4672

object_name: Bladder cancer recurrent


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C5447311

subject_name: COH04S1 COVID-19 vaccine


subject: UMLS:C5447311

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5204132

subject_name: Copper Cu 64-DOTA-ECL1i

object_name: Neck Carcinoma


subject: UMLS:C5204132

object_name: head and neck neoplasm


subject: UMLS:C5204132

object_name: head and neck cancer


subject: UMLS:C0784217

subject_name: salt substitutes

object_name: hypertension


subject: UMLS:C0784217

object_name: Hypertension, CTCAE


subject: UNII:HJT620308C

subject_name: SALT SUBSTITUTE


subject: UNII:HJT620308C


subject: PUBCHEM.COMPOUND:155586901

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:155586901

object_name: prostate cancer


subject: DRUGBANK:DB18982

subject_name: Saruparib


subject: DRUGBANK:DB18982


subject: UMLS:C4310352

subject_name: Spiolto Respimat

object_name: COPD, severe early onset


subject: UMLS:C4310352

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5853339

object_name: Leber congenital amaurosis


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib

object_name: Pancreas carcinoma resectable


subject: PUBCHEM.COMPOUND:78140854

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C1961144

object_name: thrombocytopenia


subject: UNII:KE3U2023NP

subject_name: Poractant alfa


subject: UNII:KE3U2023NP

object_name: acute respiratory distress syndrome


subject: CHEBI:9927

subject_name: Valsartan

object_name: Acute Ischemic Stroke


subject: CHEBI:9927

object_name: Ischemic stroke


subject: MESH:D013607

subject_name: Tablets

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE


subject: CHEBI:28177

subject_name: Theophylline


subject: UMLS:C1656525

subject_name: Selenium Yeast

object_name: malignant neoplasm of thyroid TNM staging


subject: UMLS:C1656525

object_name: Selenium deficiency


subject: UMLS:C1656525

object_name: Recurrence


subject: UMLS:C1656525

object_name: Recurrent Malignant Neoplasm


subject: UMLS:C1656525

object_name: Recurrent disease


subject: UMLS:C1656525

object_name: Recurrent tumor


subject: UMLS:C1656525

object_name: Embolism, Tumor


subject: UMLS:C1656525

object_name: Neoplasm Metastasis


subject: UMLS:C1656525

object_name: Metastasis


subject: UMLS:C1656525

object_name: Metastatic Lesion


subject: UNII:VV3HN9ZPB5

subject_name: FOLLITROPIN ALFA

object_name: hypogonadism


subject: CHEBI:81569

subject_name: Follitropin


subject: UMLS:C4759807

subject_name: TSH, alpha Subunit


subject: UMLS:C1268876

subject_name: follitropin alfa


subject: CHEBI:5523

subject_name: Goserelin


subject: UMLS:C0149473

subject_name: Zoladex


subject: CHEBI:31428

subject_name: colestilan

object_name: chronic kidney disease


subject: CHEBI:31428

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:31428

object_name: hyperphosphatemia


subject: CHEBI:31428

object_name: Serum phosphate concentrations above normal (finding)


subject: CHEBI:31428

object_name: Hyperphosphatemia, CTCAE


subject: CHEBI:6015

subject_name: Isoflurane

object_name: Emergence Delirium


subject: PUBCHEM.COMPOUND:5229907

subject_name: Fluocinolone

object_name: choroidal neovascularization


subject: PUBCHEM.COMPOUND:5229907

object_name: choroidal neovascularization (physical finding)


subject: PUBCHEM.COMPOUND:5229907

object_name: macular degeneration


subject: PUBCHEM.COMPOUND:5229907

object_name: age-related macular degeneration


subject: PUBCHEM.COMPOUND:5229907

object_name: retinitis pigmentosa 30


subject: CHEBI:31623

subject_name: Fluocinolone acetonide


subject: CHEBI:31623


subject: CHEBI:31623


subject: CHEBI:31623


subject: CHEBI:31623


subject: UNII:D0VK52NV5M

subject_name: Asimadoline

object_name: irritable bowel syndrome


subject: CHEBI:49662

subject_name: Indomethacin

object_name: pancreatitis


subject: CHEBI:49662

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:49662

object_name: Pancreatitis, CTCAE 3.0


subject: UMLS:C5854568

subject_name: Oncolytic HSV-1 R130

object_name: pancreatic neoplasm


subject: UMLS:C5854568

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5854568

object_name: malignant pancreatic neoplasm


subject: UMLS:C5854568

object_name: female reproductive organ cancer


subject: UMLS:C5854568

object_name: colorectal cancer


subject: UMLS:C5854568

object_name: colorectal carcinoma


subject: UMLS:C5854568

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5854568

object_name: Stomach cancer


subject: UMLS:C5854568

object_name: gastric cancer


subject: UMLS:C5854568

object_name: Childhood Breast Carcinoma


subject: UMLS:C5854568

object_name: breast carcinoma


subject: UMLS:C5854568

object_name: breast cancer


subject: UMLS:C5854568

object_name: liver cancer


subject: UMLS:C5854568

object_name: liver neoplasm


subject: UMLS:C5854568

object_name: Adult Liver Carcinoma


subject: UMLS:C5854568

object_name: liver carcinoma


subject: UMLS:C5854568

object_name: lung cancer


subject: UMLS:C5854568

object_name: lung neoplasm


subject: UMLS:C5854568

object_name: lung carcinoma


subject: UMLS:C5854568

object_name: carcinoma


subject: UMLS:C5854568

object_name: malignant soft tissue neoplasm


subject: UMLS:C5854568

object_name: sarcoma


subject: UNII:D2A6T4UH9C

subject_name: Centanafadine


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: type 1 diabetes mellitus


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:74947

subject_name: Thalidomide

object_name: malnutrition


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Fever


subject: CHEBI:46195

object_name: Fever symptoms (finding)


subject: CHEBI:46195

object_name: Fever, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:28527

subject_name: Rutin

object_name: ulcerative colitis


subject: CHEBI:28527

object_name: inflammatory bowel disease 1


subject: UMLS:C5544272

object_name: asthma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: prolymphocytic leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: hematologic disorder


subject: CHEBI:201431

object_name: Plasma cell myeloma recurrent


subject: CHEBI:201431


subject: CHEBI:201431

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:201431

object_name: CD4+/CD56+ hematodermic neoplasm


subject: CHEBI:201431

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:201431

object_name: mantle cell lymphoma


subject: CHEBI:201431

object_name: diffuse large B-cell lymphoma


subject: CHEBI:201431

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:201431

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:201431

object_name: Aggressive Non-Hodgkin Lymphoma


subject: CHEBI:201431

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: CHEBI:201431

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:201431

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:201431

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:201431

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:201431

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:201431

object_name: prolymphocytic leukemia


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: hematologic disorder


subject: CHEBI:4031

object_name: Plasma cell myeloma recurrent


subject: CHEBI:4031


subject: CHEBI:4031

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:4031

object_name: CD4+/CD56+ hematodermic neoplasm


subject: CHEBI:4031

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:4031

object_name: mantle cell lymphoma


subject: CHEBI:4031

object_name: diffuse large B-cell lymphoma


subject: CHEBI:4031

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:4031

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:4031

object_name: Aggressive Non-Hodgkin Lymphoma


subject: CHEBI:4031

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: CHEBI:4031

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:4031

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:4031

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:4031

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:4031

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:4031

object_name: prolymphocytic leukemia


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:9168


subject: CHEBI:9168

object_name: acute myeloid leukemia


subject: CHEBI:9168

object_name: acute lymphoblastic leukemia


subject: CHEBI:9168


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:18772499

object_name: Antibiotic resistant infection


subject: PUBCHEM.COMPOUND:18772499

object_name: Cross Infection


subject: PUBCHEM.COMPOUND:18772499

object_name: malnutrition


subject: PUBCHEM.COMPOUND:18772499

object_name: disease transmission


subject: PUBCHEM.COMPOUND:18772499

object_name: Sepsis


subject: PUBCHEM.COMPOUND:18772499

object_name: Sepsis, CTCAE


subject: UMLS:C4045833

subject_name: Decernotinib

object_name: rheumatoid arthritis


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Fasting


subject: CHEBI:17650

object_name: congenital isolated adrenocorticotropic hormone deficiency


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Hemorrhage


subject: CHEBI:34435

subject_name: p-Toluenesulfonamide

object_name: liver carcinoma


subject: UNII:R22TMY97SG

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:25476

subject_name: Angiotensina II

object_name: Cirrhosis


subject: PUBCHEM.COMPOUND:25476

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:25476

object_name: hepatorenal syndrome


subject: CHEBI:2719

subject_name: Angiotensin II


subject: CHEBI:2719


subject: CHEBI:2719


subject: PR:000036009

subject_name: angiotensin II


subject: PR:000036009


subject: PR:000036009


subject: UMLS:C5400662

subject_name: Therapeutic Angiotensin II


subject: UMLS:C5400662


subject: UMLS:C5400662


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: metastatic colorectal cancer


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: UNII:U7GBB0934J


subject: CHEBI:31355

subject_name: Carboplatin

object_name: T-Cell Lymphoma


subject: CHEBI:31355

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:91360


subject: GTOPDB:9604

object_name: ulcerative colitis


subject: GTOPDB:9604

object_name: inflammatory bowel disease 1


subject: UNII:45T8YQ8DDW

object_name: inherited lipid metabolism disorder


subject: UNII:45T8YQ8DDW

object_name: Dyslipidemia


subject: CHEMBL.COMPOUND:CHEMBL4802167


subject: CHEMBL.COMPOUND:CHEMBL4802167


subject: UMLS:C1572795

subject_name: PEA Preparation

object_name: Hypercholesterolemia


subject: PR:000009371

subject_name: kelch domain-containing protein 3


subject: UMLS:C5390939

subject_name: cedazuridine / decitabine

object_name: Myelodysplasia


subject: CHEBI:51209

subject_name: Pseudoephedrine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:51209

object_name: obesity


subject: CHEBI:51209

object_name: Obesity, CTCAE


subject: CHEBI:51209

object_name: pure autonomic failure


subject: CHEBI:51209

object_name: multiple system atrophy


subject: CHEBI:51209

object_name: hypertension


subject: CHEBI:51209

object_name: Hypertension, CTCAE


subject: CHEBI:9728

subject_name: Trimethaphan


subject: CHEBI:9728


subject: CHEBI:9728


subject: CHEBI:9728


subject: UMLS:C5854369

subject_name: Site Specific Immunomodulator QBECO


subject: UMLS:C5854369

object_name: Crohn disease


subject: UMLS:C5671089

object_name: diffuse large B-cell lymphoma


subject: UNII:DGH49JXB1F

subject_name: Alagebrium

object_name: diastolic heart failure


subject: CHEBI:78770

subject_name: ethylene glycol monododecyl ether

object_name: Gastric varix


subject: PUBCHEM.COMPOUND:2724258

subject_name: Polyethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:76459

subject_name: Heptaethylene glycol monododecyl ether


subject: CHEBI:31765

subject_name: Laureth 4


subject: UMLS:C1263450

subject_name: lauromacrogols


subject: CHEBI:134778

subject_name: Enbucrilate


subject: CHEBI:3441

subject_name: Carvedilol

object_name: coronary artery disorder


subject: CHEBI:3441

object_name: coronary atherosclerosis


subject: CHEBI:64019

subject_name: Nebivolol


subject: CHEBI:64019


subject: UNII:T8B91S15VF

object_name: Solid Neoplasm


subject: DRUGBANK:DB18901


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: attention deficit hyperactivity disorder, inattentive type


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:6012

object_name: prostate adenocarcinoma


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Albuminuria


subject: CHEBI:3011

subject_name: Benazepril


subject: CHEBI:3011


subject: CHEBI:3011


subject: GTOPDB:12962

subject_name: sotatercept

object_name: chronic kidney disease


subject: GTOPDB:12962

object_name: Chronic uremia


subject: CHEMBL.COMPOUND:CHEMBL1743073

subject_name: SOTATERCEPT


subject: CHEMBL.COMPOUND:CHEMBL1743073


subject: UMLS:C2699571


subject: UMLS:C2699571


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: bladder tumor


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:9130

subject_name: Sevoflurane


subject: UNII:CI43QFE22O

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:CI43QFE22O

object_name: Childhood Solid Neoplasm


subject: UNII:CI43QFE22O

object_name: Adult Solid Neoplasm


subject: UNII:CI43QFE22O


subject: UNII:CI43QFE22O

object_name: Disseminated Malignant Neoplasm


subject: UNII:CI43QFE22O

object_name: Embolism, Tumor


subject: UNII:CI43QFE22O

object_name: Neoplasm Metastasis


subject: UNII:CI43QFE22O

object_name: metastatic neoplasm


subject: UNII:CI43QFE22O

object_name: Solid carcinoma


subject: UMLS:C5882212

object_name: liver failure


subject: CHEMBL.COMPOUND:CHEMBL4297815

subject_name: CINREBAFUSP ALFA

object_name: HER2-positive gastric cancer


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: PUBCHEM.COMPOUND:152165

object_name: neurofibromatosis 1


subject: PUBCHEM.COMPOUND:152165

object_name: neurofibromatosis type 1


subject: PUBCHEM.COMPOUND:152165

object_name: Cutaneous neurofibroma


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: UMLS:C5222454

subject_name: Insulin Lispro Injection

object_name: type 2 diabetes mellitus


subject: CHEBI:49603

subject_name: Lapatinib

object_name: cancer


subject: CHEBI:49603

object_name: neoplasm


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:142708

object_name: Cross Infection


subject: CHEBI:142708

object_name: gram-positive bacterial infections


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: PUBCHEM.COMPOUND:54686904


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:149836


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: Parosmia


subject: CHEBI:93274

object_name: Disorder of olfactory system


subject: UMLS:C0993937

subject_name: Injection, caffeine citrate, 5 mg

object_name: apnea of prematurity


subject: UMLS:C5445188

subject_name: Caffeine Citrate Liquid Injection


subject: UMLS:C0699487

subject_name: Trental

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:28887

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: CHEBI:31355

subject_name: Carboplatin

object_name: diffuse large B-cell lymphoma


subject: CHEBI:31355


subject: CHEBI:31355


subject: UMLS:C4045849

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:53477758

object_name: pain agnosia


subject: PUBCHEM.COMPOUND:53477758

object_name: Pain insensitivity


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UNII:T1JP1KYU9O

subject_name: Flortaucipir F-18

object_name: Alzheimer disease type 1


subject: UMLS:C1579319

subject_name: pneumococcal conjugate vaccine

object_name: HIV infection


subject: UMLS:C1579319

object_name: pneumococcal infection


subject: CHEBI:48131

subject_name: Azelaic acid

object_name: central centrifugal cicatricial alopecia


subject: UNII:7XL5ISS668

subject_name: Adcetris


subject: UNII:7XL5ISS668


subject: UNII:7XL5ISS668


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:73508

subject_name: Glu-Pro

object_name: Childhood Breast Carcinoma


subject: CHEBI:73508

object_name: breast carcinoma


subject: CHEBI:73508

object_name: breast cancer


subject: PR:000006295

subject_name: acyl-CoA-binding protein


subject: PR:000006295


subject: PR:000006295


subject: PR:000008736

subject_name: BLOC-3 complex member HPS1


subject: PR:000008736


subject: PR:000008736


subject: CHEBI:74857

subject_name: Thr-Glu


subject: CHEBI:74857


subject: CHEBI:74857


subject: CHEBI:30452

subject_name: tellurium atom


subject: CHEBI:30452


subject: CHEBI:30452


subject: PR:000003640

subject_name: acyl-coenzyme A thioesterase 8


subject: PR:000003640


subject: PR:000003640


subject: CHEBI:33387

subject_name: neptunium atom


subject: CHEBI:33387


subject: CHEBI:33387


subject: CHEBI:53793

subject_name: (4-hydroxy-3-nitrophenyl)acetyl group


subject: CHEBI:53793


subject: CHEBI:53793


subject: CHEBI:73425

subject_name: Asn-Pro


subject: CHEBI:73425


subject: CHEBI:73425


subject: CHEBI:50803

subject_name: nanoparticle


subject: CHEBI:50803


subject: CHEBI:50803


subject: MESH:C058314

subject_name: nucleoprotein, Measles virus


subject: MESH:C058314


subject: MESH:C058314


subject: UMLS:C0795577

subject_name: recombinant antihemophilic factor VIII

object_name: hemophilia A


subject: UMLS:C4084378

subject_name: Kovaltry


subject: CHEBI:36796

subject_name: duloxetine

object_name: Back Pain without Radiation


subject: CHEBI:135901

subject_name: lanreotide

object_name: carcinoma


subject: CHEBI:135901

object_name: peritoneal neoplasm


subject: UMLS:C0051846

subject_name: angiopeptin

object_name: intestinal obstruction


subject: UMLS:C0051846


subject: UMLS:C0051846


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Postoperative confusion


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:83G67E21XI

subject_name: Urokinase

object_name: Rest limb pain


subject: UMLS:C0701941

subject_name: Abbokinase


subject: PR:000015226

subject_name: solute carrier organic anion transporter family member 2A1

object_name: schizoaffective disorder


subject: PR:000015226

object_name: schizophrenia 18


subject: PR:000015226

object_name: schizophrenia


subject: PR:000015226

object_name: psychosis


subject: PR:000015226

object_name: schizophreniform disorder


subject: PR:000015226

object_name: bipolar disorder


subject: DRUGBANK:DB14317

subject_name: Pomegranate

object_name: type 2 diabetes mellitus


subject: DRUGBANK:DB14317

object_name: Diabetes


subject: DRUGBANK:DB14317

object_name: diabetes mellitus


subject: DRUGBANK:DB14317

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB14317

object_name: obesity


subject: DRUGBANK:DB14317

object_name: Obesity, CTCAE


subject: DRUGBANK:DB14317

object_name: cardiovascular disorder


subject: UMLS:C1961993

subject_name: pomegranate extract


subject: UMLS:C1961993


subject: UMLS:C1961993


subject: UMLS:C1961993


subject: UMLS:C1961993


subject: UMLS:C1961993


subject: UMLS:C1961993


subject: CHEBI:143719

subject_name: H. influenzae type B capsular polysaccharide

object_name: haemophilus infectious disease


subject: CHEBI:139072

object_name: post-traumatic stress disorder


subject: CHEBI:8614

subject_name: Psilocybin


subject: PUBCHEM.COMPOUND:67439664

subject_name: Atovaquone/proguanil

object_name: malaria


subject: UMLS:C0733521

subject_name: Ara-C

object_name: adult lymphoma


subject: UMLS:C0733521

object_name: lymphoma


subject: UMLS:C0733521

object_name: pediatric lymphoma


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: UMLS:C0751598

subject_name: Alferon


subject: UMLS:C0751598


subject: UMLS:C0751598


subject: GTOPDB:7684

subject_name: lebrikizumab

object_name: dermatitis


subject: GTOPDB:7684

object_name: Eczema, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL1743035

subject_name: LEBRIKIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743035


subject: UMLS:C1881890


subject: UMLS:C1881890


subject: MESH:C557522

subject_name: Atralin Gel

object_name: rosacea


subject: CHEBI:91512

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: CHEBI:71019

subject_name: omacetaxine


subject: PUBCHEM.COMPOUND:24748

subject_name: Croscarmellose

object_name: xerophthalmia


subject: PUBCHEM.COMPOUND:24748

object_name: dry eye syndrome


subject: PUBCHEM.COMPOUND:24748

object_name: Dry Eye Syndrome, CTCAE


subject: CHEBI:31357

subject_name: Carboxymethylcellulose cellulose carboxymethyl ether


subject: CHEBI:31357


subject: CHEBI:31357


subject: CHEMBL.COMPOUND:CHEMBL2109001

subject_name: CARBOXYMETHYLCELLULOSE SODIUM


subject: CHEMBL.COMPOUND:CHEMBL2109001


subject: CHEMBL.COMPOUND:CHEMBL2109001


subject: UNII:K679OBS311

subject_name: Carboxymethylcellulose Sodium


subject: UNII:K679OBS311


subject: UNII:K679OBS311


subject: CHEBI:17754

subject_name: Glycerin


subject: CHEBI:17754


subject: CHEBI:17754


subject: PUBCHEM.COMPOUND:443314

subject_name: Polysorbate 20


subject: PUBCHEM.COMPOUND:443314


subject: PUBCHEM.COMPOUND:443314


subject: CHEBI:53426

subject_name: Polysorbate 80


subject: CHEBI:53426


subject: CHEBI:53426


subject: UMLS:C5784891

subject_name: Anti-EGFR/c-Met ADC AZD9592

object_name: head and neck neoplasm


subject: UMLS:C5784891

object_name: non-small cell lung carcinoma


subject: UMLS:C5784891

object_name: colorectal neoplasm


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:90943


subject: CHEBI:73678

object_name: blepharoconjunctivitis


subject: CHEBI:28864

subject_name: Tobramycin


subject: UMLS:C5882212

object_name: obesity


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: autoimmune thrombocytopenia


subject: CHEBI:46195

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:46195

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C4752901

subject_name: Diphenhydramine only product


subject: UMLS:C4752901


subject: UMLS:C4752901


subject: CHEBI:15765

subject_name: Levodopa

object_name: endogenous depression


subject: CHEBI:15765

object_name: major depressive disorder


subject: CHEBI:15765

object_name: gait speed decreased


subject: CHEBI:15765

object_name: dysthymic disorder


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Labor Pain


subject: CHEBI:3374

object_name: abortion


subject: CHEBI:3374

object_name: Pregnancy loss


subject: CHEBI:3374

object_name: Pregnancy Loss, CTCAE


subject: CHEBI:33283

subject_name: THIAMINE

object_name: heart failure


subject: CHEBI:33283

object_name: Heart Failure, CTCAE


subject: CHEBI:33283

object_name: beriberi


subject: CHEBI:33283

object_name: Thiamine deficiency


subject: CHEBI:33283

object_name: Decreased circulating vitamin B1 concentration


subject: CHEBI:33283

object_name: congestive heart failure


subject: CHEBI:33283

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: UMLS:C3714802


subject: UMLS:C3714802


subject: UMLS:C3714802


subject: UMLS:C3714802


subject: UMLS:C3714802


subject: UMLS:C3714802


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:18385


subject: CHEBI:18385


subject: CHEBI:18385


subject: CHEBI:18385


subject: CHEBI:18385


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Diabetic foot ulcer


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: Sepsis


subject: PUBCHEM.COMPOUND:126456119

object_name: Sepsis, CTCAE


subject: PR:000009978

subject_name: lactotransferrin


subject: PR:000009978


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UMLS:C0022942


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UniProtKB:Q8TCD2


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: T-cell prolymphocytic leukemia


subject: UNII:3A189DH42V

object_name: Recurrent T-Cell Prolymphocytic Leukemia


subject: UNII:19J3781LPM

subject_name: Itacitinib


subject: UNII:19J3781LPM


subject: CHEBI:31550

subject_name: Patupilone

object_name: castration-resistant prostate carcinoma


subject: CHEBI:64312

subject_name: Memantine

object_name: major depressive disorder


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Immunization reaction


subject: UMLS:C0042210

object_name: Vaccine adverse reaction


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: metastatic colorectal cancer


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:63618

subject_name: Pravastatin

object_name: liver cancer


subject: CHEBI:63618

object_name: liver neoplasm


subject: CHEBI:63618

object_name: Adult Liver Carcinoma


subject: CHEBI:63618

object_name: liver carcinoma


subject: UMLS:C2746073

subject_name: Somatostatin Receptor Agonist

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: UMLS:C0732165

subject_name: Somatostatin analog


subject: UMLS:C3536825

subject_name: Somatostatin Analog [EPC]


subject: MESH:C000722336

subject_name: PTX-COVID19-B COVID-19 vaccine


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: acute biphenotypic leukemia


subject: UNII:4FR53SIF3A

object_name: acute leukemia of ambiguous lineage


subject: UNII:4FR53SIF3A

object_name: Recurrent Mixed Phenotype Acute Leukemia


subject: UNII:4FR53SIF3A

object_name: Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: UNII:4FR53SIF3A

object_name: Ph-positive acute lymphoblastic leukemia


subject: UNII:4FR53SIF3A

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839

object_name: mixed phenotype acute leukemia


subject: CHEBI:70839


subject: CHEBI:70839

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:70839

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:70839

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:70839

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:70839


subject: CHEBI:70839

object_name: Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:70839


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: DRUGBANK:DB06596

object_name: pachyonychia congenita


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage II Hepatocellular Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IB Hepatocellular Carcinoma AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68646

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: CHEBI:68646

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: PUBCHEM.COMPOUND:71300869

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:71300869

object_name: chronic hepatitis C virus infection


subject: UNII:LOV58XHF8I


subject: UNII:LOV58XHF8I


subject: UMLS:C3897953

subject_name: Perflenapent Emulsion

object_name: Ischemic stroke


subject: UNII:T432289GYZ

subject_name: Sinecatechins

object_name: leukemia


subject: UNII:T432289GYZ

object_name: childhood leukemia


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: chordoma


subject: GTOPDB:9758

object_name: Effects of chemotherapy


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: Waldenstrom macroglobulinemia


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage II Rectal Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Rectal Cancer AJCC v7


subject: UNII:LIA7Z4002P

subject_name: Nadroparin

object_name: end stage renal failure


subject: UNII:LIA7Z4002P

object_name: Chronic uremia


subject: UNII:3XVL385Q0M

subject_name: Filgotinib

object_name: Crohn disease


subject: CHEBI:16359

subject_name: Cholic Acid

object_name: Smith-Lemli-Opitz syndrome


subject: UMLS:C5237721

subject_name: FAK1 Inhibitor IN10018

object_name: Stomach cancer


subject: UMLS:C5237721

object_name: gastric cancer


subject: CHEBI:31539

subject_name: Epalrestat

object_name: type 2 diabetes mellitus


subject: CHEBI:31539

object_name: Diabetes


subject: CHEBI:31539

object_name: diabetes mellitus


subject: CHEBI:28115

subject_name: Mecobalamin


subject: CHEBI:28115


subject: CHEBI:28115


subject: CHEBI:17439

subject_name: Cyanocobalamin


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: acne


subject: UMLS:C3827085

object_name: primary central nervous system lymphoma


subject: UMLS:C4722545

object_name: osteoarthritis, knee


subject: CHEBI:184472

subject_name: Nitrofurantoin

object_name: cystitis


subject: CHEBI:184472

object_name: Cystitis, CTCAE


subject: UMLS:C5401619

object_name: Coronavinae infectious disease


subject: CHEBI:74073

subject_name: Ile-Met


subject: CHEBI:74073


subject: CHEBI:30366

subject_name: imidazolide


subject: CHEBI:30366


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: PUBCHEM.COMPOUND:435949


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C5690454


subject: UMLS:C5690454


subject: UMLS:C5418109


subject: UMLS:C5418108


subject: CHEMBL.COMPOUND:CHEMBL5095291


subject: CHEMBL.COMPOUND:CHEMBL5095291


subject: UMLS:C5418105


subject: UMLS:C5418105


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)


subject: UniProtKB:P19726


subject: GTOPDB:11129


subject: GTOPDB:11129


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA


subject: UMLS:C5443462


subject: UMLS:C5443462


subject: UMLS:C0074926

subject_name: Soy Proteins

object_name: diabetic kidney disease


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: Chronic small plaque psoriasis


subject: CHEBI:17741

subject_name: N,N-dimethylformamide


subject: CHEBI:62880

subject_name: Veliparib

object_name: cancer


subject: CHEBI:62880

object_name: neoplasm


subject: CHEBI:2704

subject_name: Anastrozole

object_name: male breast carcinoma


subject: CHEBI:2704

object_name: Breast cancer recurrent


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Post-Operative Pain


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: pemphigus


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:2948

subject_name: Azathioprine


subject: PUBCHEM.COMPOUND:17753757

subject_name: Pimecrolimus

object_name: lichen sclerosus et atrophicus


subject: CHEBI:205919

subject_name: Clobetasol


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: epilepsy


subject: UMLS:C0498883

subject_name: Injection, haloperidol, up to 5 mg administered

object_name: delirium


subject: UMLS:C0498883

object_name: Delirium, CTCAE


subject: UMLS:C2987639

subject_name: Haloperidol Liquid Injection


subject: UMLS:C2987639


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: colorectal cancer


subject: CHEBI:91368

object_name: colorectal carcinoma


subject: CHEBI:91368

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Adult Gliosarcoma


subject: CHEBI:73604

object_name: gliosarcoma


subject: CHEBI:73604

object_name: Childhood Gliosarcoma


subject: CHEBI:73604

object_name: malignant glioma


subject: CHEBI:73604

object_name: glioblastoma


subject: CHEBI:73604

object_name: Childhood Glioblastoma


subject: CHEBI:73604

object_name: adult glioblastoma


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Hot Flashes, CTCAE


subject: CHEBI:42797

object_name: Hot flashes


subject: CHEBI:42797

object_name: Menopause present (finding)


subject: CHEBI:42797

object_name: Menopause


subject: UMLS:C5667061

subject_name: TGFbeta Inhibitor TU2218

object_name: Childhood Solid Neoplasm


subject: UMLS:C5667061

object_name: Adult Solid Neoplasm


subject: UMLS:C5667061

object_name: Solid Neoplasm


subject: UMLS:C5667061

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5667061

object_name: biliary tract cancer


subject: UMLS:C5667061

object_name: colorectal cancer


subject: UMLS:C5667061

object_name: colorectal carcinoma


subject: UMLS:C5667061

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5667061

object_name: liver carcinoma


subject: CHEBI:53498

subject_name: triacetylcellulose

object_name: Childhood Breast Carcinoma


subject: CHEBI:53498

object_name: breast carcinoma


subject: CHEBI:53498

object_name: breast cancer


subject: UMLS:C2962221

subject_name: TAC


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: CHEBI:40574

subject_name: acetyl group


subject: CHEBI:40574


subject: CHEBI:40574


subject: CHEBI:33337

subject_name: Actinium


subject: CHEBI:33337


subject: CHEBI:33337


subject: CHEBI:157787

subject_name: Ala-Cys


subject: CHEBI:157787


subject: CHEBI:157787


subject: PR:000004336

subject_name: acid ceramidase


subject: PR:000004336


subject: PR:000004336


subject: CHEBI:95021

subject_name: pemetrexed

object_name: adult lymphoma


subject: CHEBI:95021

object_name: lymphoma


subject: CHEBI:95021

object_name: pediatric lymphoma


subject: CHEBI:95021

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:95021

object_name: Embolism, Tumor


subject: CHEBI:95021

object_name: Neoplasm Metastasis


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:64073

object_name: Fatty Liver


subject: CHEBI:6121

subject_name: Ketamine

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:2663

subject_name: Amiodarone

object_name: Ebola hemorrhagic fever


subject: GTOPDB:10659

subject_name: bempegaldesleukin

object_name: melanoma


subject: GTOPDB:10659

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: GTOPDB:10659

object_name: metastatic melanoma


subject: GTOPDB:10659

object_name: skin melanoma


subject: CHEMBL.COMPOUND:CHEMBL4298058

subject_name: BEMPEGALDESLEUKIN


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UNII:3QJA87N40S

subject_name: Gadoxetic acid

object_name: Dyspnea


subject: UNII:3QJA87N40S

object_name: Dyspnea, CTCAE


subject: UNII:3QJA87N40S

object_name: cardiovascular surgery result: dyspnea


subject: CHEMBL.COMPOUND:CHEMBL2221312

subject_name: GADOXETIC ACID


subject: CHEMBL.COMPOUND:CHEMBL2221312


subject: CHEMBL.COMPOUND:CHEMBL2221312


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: Crohn disease


subject: UMLS:C5417978

subject_name: Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01

object_name: non-small cell lung carcinoma


subject: UNII:LR3UXN0193

subject_name: Methoxy polyethylene glycol-epoetin beta

object_name: lung cancer


subject: UNII:LR3UXN0193

object_name: lung neoplasm


subject: UNII:LR3UXN0193

object_name: lung carcinoma


subject: UNII:NV6352Y6TV

object_name: asthma


subject: CHEMBL.COMPOUND:CHEMBL4802195

subject_name: ATULIFLAPON


subject: UMLS:C4053647

object_name: Alzheimer disease


subject: UNII:OLF97F86A7

subject_name: Galidesivir

object_name: Marburg hemorrhagic fever


subject: CHEBI:28584

subject_name: Gossypol


subject: UNII:2M2GGL7HUP

subject_name: FOLLITROPIN DELTA

object_name: paroxysmal familial ventricular fibrillation


subject: UNII:2M2GGL7HUP

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: CHEBI:81569

subject_name: Follitropin


subject: CHEBI:81569


subject: UMLS:C4301617

subject_name: follitropin delta


subject: UMLS:C4301617


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: hypotension


subject: CHEBI:41879

object_name: Hypotension, CTCAE


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Injury of musculoskeletal system


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Overweight and obesity


subject: CHEBI:134738

subject_name: Laquinimod

object_name: multiple sclerosis


subject: CHEBI:6801

subject_name: Metformin

object_name: gastric intestinal metaplasia


subject: UNII:YNH9K62UXU

subject_name: EFAVALEUKIN ALFA

object_name: ulcerative colitis


subject: UNII:YNH9K62UXU

object_name: inflammatory bowel disease 1


subject: UMLS:C4687718

subject_name: Fc il-2 mutein fusion protein (amg-592)


subject: UMLS:C4687718


subject: CHEBI:177409

subject_name: Zicronapine

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:135565609

subject_name: Hetrombopag olamine

object_name: thrombocytopenia


subject: PUBCHEM.COMPOUND:135565609

object_name: Adverse effect of radiation therapy


subject: UMLS:C5418132

subject_name: Hetrombopag Olamine


subject: UMLS:C5418132


subject: CHEBI:125492

object_name: metastatic prostate carcinoma


subject: CHEBI:125492

object_name: Carcinoma breast stage IV


subject: CHEBI:125492

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C3827126


subject: UMLS:C3827126


subject: UMLS:C3827126


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin

object_name: end stage renal failure


subject: UMLS:C0376541

object_name: chronic kidney disease


subject: UMLS:C0376541

object_name: Chronic uremia


subject: UNII:FZ7NYF5N8L

subject_name: IRON SUCROSE

object_name: anemia


subject: UNII:FZ7NYF5N8L

object_name: Anemia, CTCAE


subject: UNII:FZ7NYF5N8L

object_name: puerperal disorder


subject: CHEBI:192761

subject_name: Iron sucrose


subject: CHEBI:192761


subject: CHEBI:192761


subject: CHEBI:30769

subject_name: Citric acid

object_name: Cough


subject: CHEBI:30769

object_name: Cough, CTCAE


subject: CHEBI:30769

object_name: asthma


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: focal segmental glomerulosclerosis


subject: CHEBI:6067

object_name: Collapsing glomerulopathy


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: intracerebral hemorrhage


subject: CHEBI:5118

object_name: Motor impairment


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Pregnant


subject: CHEBI:135947

subject_name: Bazedoxifene

object_name: rheumatoid arthritis


subject: MESH:D002136

subject_name: Calcium, Dietary


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C0074926

subject_name: Soy Proteins

object_name: Muscle damage


subject: UMLS:C0074926

object_name: Skeletal muscle damage


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Carcinoma breast stage IV


subject: CHEBI:404903

subject_name: Ertapenem

object_name: bacterial infectious disease


subject: UNII:YPM97423DB

subject_name: Zidebactam


subject: CHEBI:74750

subject_name: Phe-Pro


subject: PR:000014563

subject_name: succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial


subject: CHEBI:49159

subject_name: leukotriene antagonist


subject: UMLS:C1456741

object_name: Recurrent Liver Carcinoma


subject: UNII:11ALM7A4RV

subject_name: Peretinoin


subject: DRUGBANK:DB01363

subject_name: Ephedra sinica root

object_name: Vomiting, CTCAE


subject: DRUGBANK:DB01363

object_name: Vomiting


subject: DRUGBANK:DB01363

object_name: Nausea, CTCAE_5


subject: DRUGBANK:DB01363

object_name: Nausea


subject: DRUGBANK:DB01363

object_name: Nausea, CTCAE_3


subject: UMLS:C0390643

subject_name: ma huang extract


subject: UMLS:C0390643


subject: UMLS:C0390643


subject: UMLS:C0390643


subject: UMLS:C0390643


subject: UMLS:C0885298

subject_name: Ephedra vulgaris preparation


subject: UMLS:C0885298


subject: UMLS:C0885298


subject: UMLS:C0885298


subject: UMLS:C0885298


subject: UNII:NU90V55F8I

subject_name: Sarilumab


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: squamous cell carcinoma


subject: UMLS:C4053601


subject: CHEBI:2668

subject_name: Amlodipine

object_name: HIV infection


subject: CHEBI:4708

subject_name: Doxazosin

object_name: paraganglioma


subject: PUBCHEM.COMPOUND:5378597

object_name: cardiovascular disorder


subject: CHEBI:68352

subject_name: Isoquercetin


subject: PUBCHEM.COMPOUND:16129616

subject_name: Calcitonin

object_name: spinal cord injury


subject: PUBCHEM.COMPOUND:16129616

object_name: neuralgia


subject: PUBCHEM.COMPOUND:16129616

object_name: Neuropathic pain


subject: CHEBI:135973

subject_name: Miacalcic


subject: CHEBI:135973


subject: CHEBI:135973


subject: UNII:DF35I47HCM

subject_name: CALCITONIN


subject: UNII:DF35I47HCM


subject: UNII:DF35I47HCM


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: non-small cell lung carcinoma


subject: CHEBI:135673

subject_name: Rupatadine

object_name: kidney failure


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: hypotension


subject: CHEBI:73604

object_name: Hypotension, CTCAE


subject: CHEBI:73604

object_name: cesarean section; complications


subject: CHEBI:73604

object_name: adverse effect


subject: CHEBI:73604

object_name: Adverse effects


subject: CHEBI:73604

object_name: Adverse reactions


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:18357

subject_name: Norepinephrine


subject: UNII:3I1803DK5Z

object_name: Alzheimer disease type 1


subject: UNII:3I1803DK5Z

object_name: Alzheimer disease


subject: UNII:3I1803DK5Z

object_name: Presenile dementia


subject: UNII:3I1803DK5Z

object_name: dementia


subject: UMLS:C4305865


subject: PUBCHEM.COMPOUND:6320532

subject_name: Cenicriviroc

object_name: AIDS


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir


subject: CHEBI:6931

subject_name: Midazolam


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: endometrial cancer


subject: UNII:GKF8S4C432

object_name: uterine corpus cancer


subject: UNII:GKF8S4C432

object_name: endometrial carcinoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: end stage renal failure


subject: CHEBI:85078

object_name: Stage 4 chronic kidney disease


subject: UMLS:C4053664

object_name: Metastatic Breast Carcinoma in the Liver


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:32090

subject_name: Rebamipide

object_name: gastric ulcer


subject: CHEBI:32090

object_name: Stomach Ulcer, CTCAE


subject: UMLS:C4331423

subject_name: Traditional Chinese Medicine Formulation

object_name: Advanced Lung Adenocarcinoma


subject: MESH:C559986

object_name: Rhinoconjunctivitis


subject: MESH:C559986

object_name: Allergy


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Nocturia


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: rectum adenocarcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Neck Carcinoma


subject: CHEBI:63605

object_name: head and neck neoplasm


subject: CHEBI:63605

object_name: head and neck cancer


subject: CHEBI:63605

object_name: adult hepatocellular carcinoma


subject: CHEBI:63605

object_name: liver cancer


subject: CHEBI:63605

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:63605

object_name: liver carcinoma


subject: CHEBI:63605

object_name: pancreatic neoplasm


subject: CHEBI:63605

object_name: exocrine pancreatic carcinoma


subject: CHEBI:63605

object_name: malignant pancreatic neoplasm


subject: CHEBI:63605

object_name: renal carcinoma


subject: CHEBI:63605

object_name: kidney neoplasm


subject: CHEBI:63605

object_name: kidney cancer


subject: CHEBI:63605

object_name: colon carcinoma


subject: CHEBI:63605

object_name: colorectal cancer


subject: CHEBI:63605

object_name: colon cancer


subject: CHEBI:63605

object_name: lung cancer


subject: CHEBI:63605

object_name: lung neoplasm


subject: CHEBI:63605

object_name: lung carcinoma


subject: CHEBI:63605

object_name: malignant soft tissue neoplasm


subject: CHEBI:63605

object_name: sarcoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Neck Carcinoma


subject: CHEBI:71219

object_name: head and neck neoplasm


subject: CHEBI:71219

object_name: head and neck cancer


subject: CHEBI:71219

object_name: adult hepatocellular carcinoma


subject: CHEBI:71219

object_name: liver cancer


subject: CHEBI:71219

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:71219

object_name: liver carcinoma


subject: CHEBI:71219

object_name: pancreatic neoplasm


subject: CHEBI:71219

object_name: exocrine pancreatic carcinoma


subject: CHEBI:71219

object_name: malignant pancreatic neoplasm


subject: CHEBI:71219

object_name: renal carcinoma


subject: CHEBI:71219

object_name: kidney neoplasm


subject: CHEBI:71219

object_name: kidney cancer


subject: CHEBI:71219

object_name: Childhood Breast Carcinoma


subject: CHEBI:71219

object_name: breast carcinoma


subject: CHEBI:71219

object_name: breast cancer


subject: CHEBI:71219

object_name: colon carcinoma


subject: CHEBI:71219

object_name: colorectal cancer


subject: CHEBI:71219

object_name: colon cancer


subject: CHEBI:71219

object_name: lung cancer


subject: CHEBI:71219

object_name: lung neoplasm


subject: CHEBI:71219

object_name: lung carcinoma


subject: CHEBI:71219

object_name: malignant soft tissue neoplasm


subject: UMLS:C5418085

subject_name: MCL-1 Inhibitor ABBV-467

object_name: plasma cell myeloma


subject: UMLS:C5418085

object_name: cancer


subject: UMLS:C5418085

object_name: neoplasm


subject: UNII:E1C0J49GTW


subject: UNII:E1C0J49GTW


subject: UNII:E1C0J49GTW


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: cervical carcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: UMLS:C3896932

object_name: Lung squamous cell carcinoma recurrent


subject: UMLS:C3896932

object_name: Stage IV Lung Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: pancreatic neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:131769963

object_name: Neuroendocrine tumor of pancreas


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: CHEBI:6504

object_name: Gastrointestinal complication


subject: CHEBI:6504

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:6504

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:6504

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:6504

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:6504

object_name: Poor Prognosis Metastatic Gestational Trophoblastic Tumor


subject: CHEBI:6504

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:6504

object_name: Testis cancer recurrent


subject: CHEBI:6504

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:6504

object_name: stage III testicular cancer


subject: CHEBI:6504

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:6504

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:6504

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:6504

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:6504

object_name: MALT lymphoma


subject: CHEBI:6504

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:6504

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:6504

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:6504

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:6504

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:6504

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:6504

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:6504

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:6504

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:6504

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:6504


subject: CHEBI:6504

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:6504

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:6504

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:6504

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:6504

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:6504

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:6504

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:6504

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:6504

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:6504

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:6504

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:6504

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:6504

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:6504

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:6504

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:6504

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:6504

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:6504

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:6504

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:6504

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:6504

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: CHEBI:6504

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:6504

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:6504

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:6504

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:6504

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:6504

object_name: Blast Phase


subject: CHEBI:6504

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:6504

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:6504

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:6504

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:6504

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:6504

object_name: Mantle cell lymphoma stage III


subject: CHEBI:6504

object_name: refractory hairy cell leukemia


subject: CHEBI:6504

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:6504

object_name: Recurrent ovarian cancer


subject: CHEBI:6504

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:6504

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:6504

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:6504

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:6504

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:6504

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:6504

object_name: Ovarian cancer stage III


subject: CHEBI:6504

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:6504

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:6504

object_name: Ovarian cancer stage IV


subject: CHEBI:6504

object_name: Ovarian epithelial cancer stage II


subject: CHEBI:6504

object_name: Marginal zone lymphoma stage III


subject: CHEBI:6504

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:6504

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:6504

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:6504

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:6504

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:6504

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:6504

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:6504

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:6504

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:6504

object_name: childhood myelodysplastic syndrome


subject: CHEBI:6504

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:6504

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:6504

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:6504

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:6504

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:6504

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:6504

object_name: splenic marginal zone lymphoma


subject: CHEBI:6504

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:6504

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:6504

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:6504

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:6504

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:6504

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:6504

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:6504

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:6504

object_name: chronic myelomonocytic leukemia


subject: CHEBI:6504

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:6504

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:6504

object_name: chronic eosinophilic leukemia


subject: CHEBI:6504

object_name: chronic neutrophilic leukemia


subject: CHEBI:6504

object_name: Disseminated neuroblastoma


subject: CHEBI:6504

object_name: Stage 4S neuroblastoma


subject: CHEBI:6504

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:6504

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:6504

object_name: Neuroblastoma recurrent


subject: CHEBI:6504

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:6504

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:6504

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:6504

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:6504

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:6504

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:6504

object_name: ISS Stage I Plasma Cell Myeloma


subject: CHEBI:6504

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:6504

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:6504

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:6504

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:6504

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:6504

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:6504

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:6504

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:6504

object_name: Carcinoma breast stage IV


subject: CHEBI:6504

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:6504

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:6504

object_name: myelofibrosis


subject: UMLS:C0733521

subject_name: Ara-C

object_name: leukemia


subject: UMLS:C0733521

object_name: childhood leukemia


subject: UNII:8U8J5ASV94

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:8U8J5ASV94

object_name: amyotrophic lateral sclerosis


subject: UMLS:C5853403


subject: UMLS:C5853403


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Minimal hepatic encephalopathy


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Prostate Adenocarcinoma without Neuroendocrine Differentiation


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: PUBCHEM.COMPOUND:131674970

subject_name: CEFTRIAXONE SODIUM

object_name: Sepsis


subject: PUBCHEM.COMPOUND:131674970

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:131674970

object_name: Decreased liver function


subject: CHEBI:3514

subject_name: Ceftriaxone disodium salt hemiheptahydrate


subject: CHEBI:3514


subject: CHEBI:3514


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: CHEBI:29007


subject: CHEBI:29007


subject: CHEBI:28115

subject_name: Mecobalamin


subject: CHEBI:28115


subject: CHEBI:28115


subject: CHEBI:17439

subject_name: Cyanocobalamin


subject: CHEBI:17439


subject: CHEBI:17439


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Localized Gastric Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage 0 Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage 0 Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage I Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Localized Gastroesophageal Junction Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: Localized Gastric Carcinoma


subject: CHEBI:46345

object_name: Clinical Stage 0 Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage 0 Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage I Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IA Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: CHEBI:46345

object_name: Localized Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:46345

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

subject_name: ipilimumab

object_name: gastric adenocarcinoma


subject: CHEBI:231679

object_name: Localized Gastric Carcinoma


subject: CHEBI:231679

object_name: Clinical Stage 0 Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage 0 Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage I Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IA Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: CHEBI:231679

object_name: Localized Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:231679

object_name: Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231679

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Localized Gastric Carcinoma


subject: CHEBI:231614

object_name: Clinical Stage 0 Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage 0 Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage I Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IA Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: CHEBI:231614

object_name: Localized Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:231614

object_name: Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231614

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Localized Gastric Carcinoma


subject: UMLS:C2346820

object_name: Clinical Stage 0 Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage 0 Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage I Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IA Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: UMLS:C2346820

object_name: Localized Gastroesophageal Junction Adenocarcinoma


subject: UMLS:C2346820

object_name: Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C2346820

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Localized Gastric Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage 0 Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage 0 Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage I Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Localized Gastroesophageal Junction Adenocarcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED

object_name: Localized Gastric Carcinoma


subject: UMLS:C1314429

object_name: Clinical Stage 0 Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Clinical Stage I Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Clinical Stage IIB Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage 0 Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage I Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IA Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IB Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IIB Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IIA Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: UMLS:C1314429

object_name: Localized Gastroesophageal Junction Adenocarcinoma


subject: UMLS:C1314429

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: DRUGBANK:DB15654

subject_name: Moderna COVID-19 Vaccine

object_name: long COVID-19


subject: UMLS:C5565871

subject_name: Paxlovid


subject: CHEBI:192712


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: carcinoma of esophagus


subject: UMLS:C2346492

object_name: esophageal cancer


subject: UMLS:C2346492

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C2346492

object_name: neoplasm of esophagus


subject: CHEBI:84363

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:84363

object_name: metabolic syndrome X


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:2376


subject: UNII:249EAP69MT

subject_name: COFETUZUMAB PELIDOTIN

object_name: non-small cell lung carcinoma